e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer
E. C. Seyhan, S. Altin, S. N. Sökücü, L. Karasulu, H. Abali, N. Büyükpinarbasili, H. Can (Istanbul, Turkey)
Source:
Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Session:
Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Session type:
E-Communication Session
Number:
1440
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. C. Seyhan, S. Altin, S. N. Sökücü, L. Karasulu, H. Abali, N. Büyükpinarbasili, H. Can (Istanbul, Turkey). ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer. Eur Respir J 2009; 34: Suppl. 53, 1440
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Her/2 neu and p53 expression in patients with non-small cell lung cancer predict shortened survival
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005
p-53 and HER2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
Analysis of the prognosis value of the mitochondrial activity in resected non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Expression of ERCC1 in normal and tumor tissues in non-small cell lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Tumour metabolic-flow difference as a potential predictor of survival in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004
Early recurrence in complete resected non-small cell lung cancer patients
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
A variant in LKB1 gene can predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018
Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy
Source: Eur Respir Rev 2013; 22: 565-576
Year: 2013
Relation between ERCC1 expression in sputum and survival after cisplatin-based chemotherapy in non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 78s
Year: 2005
Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient
Source: Eur Respir J 2015; 46: 280-282
Year: 2015
Risk factor for survival in never-smokers non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept